Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
FierceBiotech
When Spray Drying Falls Short: A Faster Path Forward
FierceBiotech
Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win
FierceBiotech
Roche boosts diagnostics offerings with $595M Saga buyout
FierceBiotech
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
FierceBiotech
Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody
Moderna
What's Pushing Moderna Stock Higher Today? - Benzinga
Novo Nordisk
Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Abbott
Diane Abbott criticises Keir Starmer over Peter Mandelson vetting process - Sky News
Intuitive Surgical
Intuitive Surgical Q1 2026 Earnings Preview (ISRG:NASDAQ) - Seeking Alpha
Thermo Fisher
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Thermo Fisher
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
BioWorld
Biggest gainers and losers for April 13-17, 2026
FierceBiotech
When Spray Drying Falls Short: A Faster Path Forward
FierceBiotech
Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win
FierceBiotech
Roche boosts diagnostics offerings with $595M Saga buyout
FierceBiotech
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
FierceBiotech
Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody
Moderna
What's Pushing Moderna Stock Higher Today? - Benzinga
Novo Nordisk
Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Abbott
Diane Abbott criticises Keir Starmer over Peter Mandelson vetting process - Sky News
Intuitive Surgical
Intuitive Surgical Q1 2026 Earnings Preview (ISRG:NASDAQ) - Seeking Alpha
Thermo Fisher
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Thermo Fisher
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
BioWorld
Biggest gainers and losers for April 13-17, 2026
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioPharma Dive
Total
8
Source
BioPharma Dive
Recherche
Roche
BioPharma Dive
10 avr. 2026
RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
BioPharma Dive
20 mars 2026
Roche stops work on experimental SMA drug
BioPharma Dive
9 mars 2026
Roche’s prized breast cancer pill fails closely watched study
BioPharma Dive
6 mars 2026
Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results
BioPharma Dive
2 mars 2026
Roche pill succeeds in another MS study, but approval questions linger
BioPharma Dive
20 févr. 2026
Roche gets FDA decision date on closely watched breast cancer drug
BioPharma Dive
9 févr. 2026
Lilly bets again on China drugs; Roche showcases MS data
BioPharma Dive
27 janv. 2026
Roche, trailing in obesity, showcases new data for GLP-1 shot